![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Tag: Coronavirus information (COVID-19)
Press Releases
Informa Pharma Intelligence Announces COVID-19 24-Hour Webinar Series
Informa Pharma Intelligence, announces an upcoming free 24-hour interactive webinar series entitled COVID-19 24-hour Web Event: Lessons Learned and a Path Forward. The event...
Drug Research
Biocair transports COVID-19 antibody tests for the German Football Association
As part of the agreement, Biocair will transport selected blood samples to specialist laboratories for investigation to find out if the individual has developed...
Drug Research
Catalent Partners with ViralClear Pharmaceuticals on Potential Treatment for COVID-19
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...
Clinical Trials
Symbiosis and AstraZeneca Sign Supply Agreement for Sterile Manufacture of COVID-19 Vaccine for Clinical Trials
Symbiosis Pharmaceutical Services, a specialist provider of pharmaceutical and vaccine development services, has announced it has signed a supply agreement with AstraZeneca for sterile...
Press Releases
Hetero announces the approval and launch of first generic COVIFOR in India for the treatment of Covid-19
Hetero, one of India’s leading generic pharmaceutical companies, announced that it has received the manufacturing and marketing approval for the investigational antiviral medicine ‘Remdesivir’...
Clinical Trials
PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19
PTC Therapeutics, Inc. announced that the U.S. FDA has authorized the initiation of a Phase 2/3 trial to investigate PTC299, a dihydroorotate dehydrogenase (DHODH)...
Press Releases
Glenmark becomes the first pharmaceutical company in India to receive regulatory approval for oral antiviral Favipiravir, for the treatment of mild to moderate COVID-19
In a landmark development for COVID-19 patients in India, Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the launch of antiviral drug Favipiravir...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read